Chimeric clocks $4.17M R&D tax rebate from Canberra
Microcap Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17 million…
Chimeric Therapeutics Limited (ASX:CHM)
About Chimeric Therapeutics Limited
Key Information
CHM In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 09.38am 28/11/2024 | Price Sensitive PS Chimeric receives $4.17m R&D tax incentive | 174.74KB | 1.6K |
| 14/11/2024 | Constitution | 615.29KB | 459 |
| 12/11/2024 | Results of Meeting | 271.39KB | 6.0K |
| 12/11/2024 | Price Sensitive PS AGM Presentation and CEO Appointment | 13.52MB | 6.0K |
| 05/11/2024 | Notice under section 708A | 206.37KB | 388 |
| 05/11/2024 | Application for quotation of securities - CHM | 15.82KB | 355 |
| 05/11/2024 | Notice of Extraordinary General Meeting December 2024 | 374.55KB | 480 |
| 30/10/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 906.01KB | 437 |